Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients: The State of the Art and Open Issues

Conflicting results have been reported so far in pooled analyses and studies evaluating the optimum duration of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS) patients. However, randomized clinical trials dedicated to this specific setting of higher thrombotic risk patients have o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cardiovasc Ther
Главные авторы: Verdoia, Monica, Camaro, Cyril, Kedhi, Elvin, Marcolongo, Marco, Suryapranata, Harry, De Luca, Giuseppe
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2020
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7166288/
https://ncbi.nlm.nih.gov/pubmed/32328172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/6495036
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы